Monoclonal antibodies to serine proteases from the venom of B. Jararaca: generation of hybridomas

Key Points

• The aim is to generate monoclonal antibodies targeting serine proteases derived from B. jararaca venom.
• Hybridoma technology is employed to produce monoclonal antibodies.
• Venom components are processed to identify target serine proteases.
• Presentation at the International Symposium on Immunobiologicals is described.
• Findings indicate successful generation of hybridomas for serine proteases.
• Potential applications in immunobiological research are highlighted.

Abstract